Trade Summary

2 days ago, Rtw Investments, LP, serving as 10% owner at Kailera Therapeutics, Inc. (KLRA), purchased 500,000 shares at $16.00 per share, for a total transaction value of $8,000,000.00. Following this transaction, Rtw Investments, LP now holds 10,776,820 shares of KLRA.

This purchase represents a 5.00% increase in Rtw Investments, LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, April 20, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 22, 2026, 2 days after the trade was made.

Kailera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.